Advanced

Is Rituximab a Potential New Therapy in Systemic Sclerosis?: New Evidence Indicates the Presence of CD20-Positive B-lymphocytes in Scleroderma Skin.

Wollheim, Frank LU (2004) In Journal of Clinical Rheumatology 10(3). p.155-155
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Rheumatology
volume
10
issue
3
pages
155 - 155
publisher
Lippincott Williams & Wilkins
external identifiers
  • wos:000222280300015
  • scopus:3042638778
ISSN
1536-7355
language
English
LU publication?
yes
id
83d4cefc-a4bf-438a-92ba-dbad567e453a (old id 162324)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17043493&dopt=Abstract
date added to LUP
2007-07-12 16:52:43
date last changed
2017-11-05 04:30:10
@article{83d4cefc-a4bf-438a-92ba-dbad567e453a,
  author       = {Wollheim, Frank},
  issn         = {1536-7355},
  language     = {eng},
  number       = {3},
  pages        = {155--155},
  publisher    = {Lippincott Williams & Wilkins},
  series       = {Journal of Clinical Rheumatology},
  title        = {Is Rituximab a Potential New Therapy in Systemic Sclerosis?: New Evidence Indicates the Presence of CD20-Positive B-lymphocytes in Scleroderma Skin.},
  volume       = {10},
  year         = {2004},
}